Your browser doesn't support javascript.
loading
The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts.
Nikpour, Maryam; Scharenberg, Christian; Liu, Anquan; Conte, Simona; Karimi, Mohsen; Mortera-Blanco, Teresa; Giai, Valentina; Fernandez-Mercado, Marta; Papaemmanuil, Elli; Högstrand, Kari; Jansson, Monika; Vedin, Inger; Wainscoat, James Stephen; Campbell, Peter; Cazzola, Mario; Boultwood, Jacqueline; Grandien, Alf; Hellström-Lindberg, Eva.
Afiliação
  • Nikpour M; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Scharenberg C; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Liu A; Department of Medicine, Skaraborgs Hospital, Skovde, Sweden.
  • Conte S; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Karimi M; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Mortera-Blanco T; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Giai V; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Fernandez-Mercado M; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Papaemmanuil E; LLR Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK.
  • Högstrand K; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK, Department of Haematology, University of Cambridge, Cambridge, UK.
  • Jansson M; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Vedin I; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Wainscoat JS; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Campbell P; LLR Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK.
  • Cazzola M; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK, Department of Haematology, University of Cambridge, Cambridge, UK.
  • Boultwood J; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Grandien A; LLR Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK.
  • Hellström-Lindberg E; Karolinska Institutet, Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Leukemia ; 27(4): 889-896, 2013 Apr.
Article em En | MEDLINE | ID: mdl-23070040
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Refratária / Transportadores de Cassetes de Ligação de ATP / Anemia Sideroblástica Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Refratária / Transportadores de Cassetes de Ligação de ATP / Anemia Sideroblástica Idioma: En Ano de publicação: 2013 Tipo de documento: Article